Can Gaming Get You Fit? A High-Intensity Exergaming Intervention in Adults

Sedentary Lifestyle Clinical Trial

Official title:

Motivational High Intensity Training Through a Cutting-edge Gaming Platform. A Randomised, Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03513380
• Other study ID #: 2017/1501
• Status: Completed
• Phase: N/A
• Start date: May 25, 2018
• Est. completion date: November 30, 2019

Study information

• Verified date: December 2019
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to health benefits. The project will include 50 adult participants that are not particularly physically active. They will be randomized into two groups where one group will be given free access to the exergame for 6 months. The physical fitness (maximal oxygen consumption), blood markers of cardiometabolic health and body composition of the subjects will be tested before, mid-ways and after the intervention period. Also, the participants gaming frequency will be registered throughout the 6-month period. Aim of this study is to investigate if access to this game can provide health benefits for individuals who are not motivated to take part in regular physical activity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 52
• Est. completion date: November 30, 2019
• Est. primary completion date: November 30, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Sedentary (<150 mins of moderate intensity physical activity/week)

• Able to ride a bike for up to 60 minutes

Exclusion Criteria:

• Known cardiovascular disease

• Taking beta-blockers or anti-arrhythmic drugs

Related Conditions & MeSH terms

• Sedentary Lifestyle

Intervention

Behavioral:
• Exergaming
free access to the exergame PedalTanks during 6 months

Locations

Country	Name	City	State
Norway	Department of Circulation and Medical Imaging	Trondheim

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	VO2max (Maximal Aerobic Capacity)		3 months
Primary	VO2max (Maximal Aerobic Capacity)		6 months
Secondary	Daily average energy expenditure	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Daily average number of steps	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Daily average total physical activity duration	Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.	3 and 6 months
Secondary	Bioelectrical impedance	Body composition assessed using bioelectrical impedance analysis (InBody 720)	3 and 6 months
Secondary	Blood Pressure		3 and 6 months
Secondary	Fasting circulating glucose, as blood marker of cardiometabolic health		6 months
Secondary	Lipid profile, as blood marker of cardiometabolic health		6 months
Secondary	Circulating insulin concentration, as blood marker of cardiometabolic health		6 months
Secondary	glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health		6 months